Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning

The src-homology 2 domain-containing phosphatase 2 (SHP2) is a human cytoplasmic protein tyrosine phosphatase that plays a crucial role in cellular signal transduction. Aberrant activation and mutations of SHP2 are associated with tumor growth and immune suppression, thus making it a potential targe...

Full description

Saved in:
Bibliographic Details
Main Authors: Baerlike Wujieti, Mingtian Hao, Erxia Liu, Luqi Zhou, Huanchao Wang, Yu Zhang, Wei Cui, Bozhen Chen
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Molecules
Subjects:
Online Access:https://www.mdpi.com/1420-3049/30/1/14
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841549167736913920
author Baerlike Wujieti
Mingtian Hao
Erxia Liu
Luqi Zhou
Huanchao Wang
Yu Zhang
Wei Cui
Bozhen Chen
author_facet Baerlike Wujieti
Mingtian Hao
Erxia Liu
Luqi Zhou
Huanchao Wang
Yu Zhang
Wei Cui
Bozhen Chen
author_sort Baerlike Wujieti
collection DOAJ
description The src-homology 2 domain-containing phosphatase 2 (SHP2) is a human cytoplasmic protein tyrosine phosphatase that plays a crucial role in cellular signal transduction. Aberrant activation and mutations of SHP2 are associated with tumor growth and immune suppression, thus making it a potential target for cancer therapy. Initially, researchers sought to develop inhibitors targeting SHP2’s catalytic site (protein tyrosine phosphatase domain, PTP). Due to limitations such as conservativeness and poor membrane permeability, SHP2 was once considered a challenging drug target. Nevertheless, with the in-depth investigations into the conformational switch mechanism from SHP2’s inactive to active state and the emergence of various SHP2 allosteric inhibitors, new hope has been brought to this target. In this study, we investigated the interaction models of various allosteric inhibitors with SHP2 using molecular dynamics simulations. Meanwhile, we explored the free energy landscape of SHP2 activation using enhanced sampling technique (meta-dynamics simulations), which provides insights into its conformational changes and activation mechanism. Furthermore, to biophysically interpret high-dimensional simulation trajectories, we employed interpretable machine learning methods, specifically extreme gradient boosting (XGBoost) with Shapley additive explanations (SHAP), to comprehensively analyze the simulation data. This approach allowed us to identify and highlight key structural features driving SHP2 conformational dynamics and regulating the activity of the allosteric inhibitor. These studies not only enhance our understanding of SHP2’s conformational switch mechanism but also offer crucial insights for designing potent allosteric SHP2 inhibitors and addressing drug resistance issues.
format Article
id doaj-art-a835065c50044eada310018f83b91e34
institution Kabale University
issn 1420-3049
language English
publishDate 2024-12-01
publisher MDPI AG
record_format Article
series Molecules
spelling doaj-art-a835065c50044eada310018f83b91e342025-01-10T13:18:36ZengMDPI AGMolecules1420-30492024-12-013011410.3390/molecules30010014Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine LearningBaerlike Wujieti0Mingtian Hao1Erxia Liu2Luqi Zhou3Huanchao Wang4Yu Zhang5Wei Cui6Bozhen Chen7School of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaSchool of Chemical Sciences, University of Chinese Academy of Sciences, No. 19A, Yuquan Road, Beijing 100049, ChinaThe src-homology 2 domain-containing phosphatase 2 (SHP2) is a human cytoplasmic protein tyrosine phosphatase that plays a crucial role in cellular signal transduction. Aberrant activation and mutations of SHP2 are associated with tumor growth and immune suppression, thus making it a potential target for cancer therapy. Initially, researchers sought to develop inhibitors targeting SHP2’s catalytic site (protein tyrosine phosphatase domain, PTP). Due to limitations such as conservativeness and poor membrane permeability, SHP2 was once considered a challenging drug target. Nevertheless, with the in-depth investigations into the conformational switch mechanism from SHP2’s inactive to active state and the emergence of various SHP2 allosteric inhibitors, new hope has been brought to this target. In this study, we investigated the interaction models of various allosteric inhibitors with SHP2 using molecular dynamics simulations. Meanwhile, we explored the free energy landscape of SHP2 activation using enhanced sampling technique (meta-dynamics simulations), which provides insights into its conformational changes and activation mechanism. Furthermore, to biophysically interpret high-dimensional simulation trajectories, we employed interpretable machine learning methods, specifically extreme gradient boosting (XGBoost) with Shapley additive explanations (SHAP), to comprehensively analyze the simulation data. This approach allowed us to identify and highlight key structural features driving SHP2 conformational dynamics and regulating the activity of the allosteric inhibitor. These studies not only enhance our understanding of SHP2’s conformational switch mechanism but also offer crucial insights for designing potent allosteric SHP2 inhibitors and addressing drug resistance issues.https://www.mdpi.com/1420-3049/30/1/14molecular dockingmolecular dynamics simulationsMM/GBSA binding free energy calculationsenhanced samplingmachine learning
spellingShingle Baerlike Wujieti
Mingtian Hao
Erxia Liu
Luqi Zhou
Huanchao Wang
Yu Zhang
Wei Cui
Bozhen Chen
Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning
Molecules
molecular docking
molecular dynamics simulations
MM/GBSA binding free energy calculations
enhanced sampling
machine learning
title Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning
title_full Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning
title_fullStr Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning
title_full_unstemmed Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning
title_short Study on SHP2 Conformational Transition and Structural Characterization of Its High-Potency Allosteric Inhibitors by Molecular Dynamics Simulations Combined with Machine Learning
title_sort study on shp2 conformational transition and structural characterization of its high potency allosteric inhibitors by molecular dynamics simulations combined with machine learning
topic molecular docking
molecular dynamics simulations
MM/GBSA binding free energy calculations
enhanced sampling
machine learning
url https://www.mdpi.com/1420-3049/30/1/14
work_keys_str_mv AT baerlikewujieti studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT mingtianhao studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT erxialiu studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT luqizhou studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT huanchaowang studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT yuzhang studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT weicui studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning
AT bozhenchen studyonshp2conformationaltransitionandstructuralcharacterizationofitshighpotencyallostericinhibitorsbymoleculardynamicssimulationscombinedwithmachinelearning